Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SIR-9900 by Sironax for Neurodegenerative Diseases: Likelihood of Approval
SIR-9900 is under clinical development by Sironax and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase I...
Data Insights
SIR-9900 by Sironax for Inflammation: Likelihood of Approval
SIR-9900 is under clinical development by Sironax and currently in Phase I for Inflammation. According to GlobalData, Phase I drugs...